FF:11790-124B8: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 69: | Line 69: | ||
|sample_ethnicity= | |sample_ethnicity= | ||
|sample_experimental_condition= | |sample_experimental_condition= | ||
|sample_gostat=GO:0044464;cell part;0!GO:0005622;intracellular;0!GO:0044424;intracellular part;3.71522166330558e-212!GO:0043227;membrane-bound organelle;1.94174016435176e-167!GO:0043231;intracellular membrane-bound organelle;3.70342505543283e-167!GO:0043226;organelle;3.59755540957825e-155!GO:0043229;intracellular organelle;2.12205250523418e-154!GO:0005737;cytoplasm;1.75433751687454e-147!GO:0044444;cytoplasmic part;3.20331874352845e-106!GO:0044422;organelle part;2.01400463993138e-100!GO:0044446;intracellular organelle part;1.07017174701771e-98!GO:0032991;macromolecular complex;1.14217931600029e-86!GO:0044237;cellular metabolic process;1.85967653640593e-85!GO:0044238;primary metabolic process;9.6536898897706e-81!GO:0043170;macromolecule metabolic process;5.29065997003997e-78!GO:0030529;ribonucleoprotein complex;5.67930170736744e-77!GO:0005634;nucleus;3.56400215037539e-68!GO:0003723;RNA binding;2.34202629825477e-65!GO:0005739;mitochondrion;5.8373801736906e-61!GO:0044428;nuclear part;5.99211089890648e-61!GO:0043233;organelle lumen;2.6603800346755e-56!GO:0031974;membrane-enclosed lumen;2.6603800346755e-56!GO:0006412;translation;2.01766388081211e-54!GO:0019538;protein metabolic process;1.39737447658773e-47!GO:0005515;protein binding;6.45413384242925e-47!GO:0005840;ribosome;5.05752508455942e-46!GO:0044267;cellular protein metabolic process;1.18490072341476e-45!GO:0044260;cellular macromolecule metabolic process;1.25482234310063e-45!GO:0033036;macromolecule localization;8.21752618004225e-45!GO:0010467;gene expression;1.36845633299317e-44!GO:0043283;biopolymer metabolic process;3.27448536242015e-44!GO:0015031;protein transport;8.604510563899e-44!GO:0043234;protein complex;2.5229458048652e-43!GO:0045184;establishment of protein localization;2.80549207004158e-43!GO:0006396;RNA processing;8.42117570715263e-43!GO:0008104;protein localization;6.4433443942756e-42!GO:0044429;mitochondrial part;7.97566177952438e-42!GO:0009059;macromolecule biosynthetic process;3.40222640453213e-41!GO:0003735;structural constituent of ribosome;3.90012447299769e-41!GO:0031090;organelle membrane;5.43858928805718e-40!GO:0005829;cytosol;6.10339768561904e-38!GO:0031967;organelle envelope;1.17308260315446e-37!GO:0031975;envelope;2.51688562859313e-37!GO:0044249;cellular biosynthetic process;3.07038423230165e-37!GO:0033279;ribosomal subunit;3.81134696381061e-37!GO:0016071;mRNA metabolic process;3.89096535599795e-37!GO:0009058;biosynthetic process;6.35120999466252e-37!GO:0006139;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;1.16437384218259e-36!GO:0031981;nuclear lumen;1.2822665993077e-36!GO:0008380;RNA splicing;1.61650256101808e-34!GO:0006397;mRNA processing;2.5196805626284e-32!GO:0005830;cytosolic ribosome (sensu Eukaryota);1.23791711883227e-28!GO:0006886;intracellular protein transport;5.45970424735321e-28!GO:0046907;intracellular transport;6.71897292329663e-28!GO:0005740;mitochondrial envelope;1.1309285071638e-27!GO:0031966;mitochondrial membrane;8.256949178489e-27!GO:0016043;cellular component organization and biogenesis;1.41654938248983e-26!GO:0065003;macromolecular complex assembly;3.23638512153333e-26!GO:0019866;organelle inner membrane;8.45692653743968e-26!GO:0005681;spliceosome;1.00727727527577e-25!GO:0022613;ribonucleoprotein complex biogenesis and assembly;1.86535497421217e-25!GO:0044445;cytosolic part;5.90186999256688e-25!GO:0005654;nucleoplasm;1.29703450071891e-24!GO:0006119;oxidative phosphorylation;1.99027531324298e-24!GO:0005743;mitochondrial inner membrane;1.26332966201026e-23!GO:0003676;nucleic acid binding;2.06410064143113e-23!GO:0022607;cellular component assembly;7.25190062648363e-22!GO:0044455;mitochondrial membrane part;1.93302336541686e-21!GO:0051649;establishment of cellular localization;1.77266163274703e-20!GO:0051641;cellular localization;5.40567063605929e-20!GO:0000166;nucleotide binding;1.00784568034829e-19!GO:0044451;nucleoplasm part;1.07982754082383e-19!GO:0006259;DNA metabolic process;1.1437101192542e-19!GO:0015935;small ribosomal subunit;1.91409891896517e-19!GO:0006915;apoptosis;2.09276036527355e-19!GO:0012501;programmed cell death;2.47630857080667e-19!GO:0006996;organelle organization and biogenesis;3.11000677817513e-19!GO:0015934;large ribosomal subunit;1.00717112827276e-18!GO:0006512;ubiquitin cycle;1.39021833109845e-18!GO:0022618;protein-RNA complex assembly;1.49425392234507e-18!GO:0016070;RNA metabolic process;1.5135805695361e-18!GO:0008219;cell death;4.98143050028145e-18!GO:0016265;death;4.98143050028145e-18!GO:0044265;cellular macromolecule catabolic process;4.98143050028145e-18!GO:0005746;mitochondrial respiratory chain;1.59296419948426e-17!GO:0031980;mitochondrial lumen;9.37280434334308e-17!GO:0005759;mitochondrial matrix;9.37280434334308e-17!GO:0043412;biopolymer modification;3.75041526370723e-16!GO:0050136;NADH dehydrogenase (quinone) activity;6.0143066589904e-16!GO:0003954;NADH dehydrogenase activity;6.0143066589904e-16!GO:0008137;NADH dehydrogenase (ubiquinone) activity;6.0143066589904e-16!GO:0016818;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;6.58034477495559e-16!GO:0008134;transcription factor binding;7.95782444028205e-16!GO:0016817;hydrolase activity, acting on acid anhydrides;8.42043137354989e-16!GO:0016462;pyrophosphatase activity;8.4417793553763e-16!GO:0005843;cytosolic small ribosomal subunit (sensu Eukaryota);9.64101834372993e-16!GO:0016874;ligase activity;1.87781035386743e-15!GO:0016655;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;2.24153479240077e-15!GO:0019941;modification-dependent protein catabolic process;2.24153479240077e-15!GO:0043632;modification-dependent macromolecule catabolic process;2.24153479240077e-15!GO:0017111;nucleoside-triphosphatase activity;2.29229723006366e-15!GO:0051603;proteolysis involved in cellular protein catabolic process;2.41971666836983e-15!GO:0000502;proteasome complex (sensu Eukaryota);2.91512616449406e-15!GO:0044257;cellular protein catabolic process;4.26365255891097e-15!GO:0006511;ubiquitin-dependent protein catabolic process;4.94154760378688e-15!GO:0044248;cellular catabolic process;6.9439322202696e-15!GO:0006605;protein targeting;8.10940347848021e-15!GO:0051186;cofactor metabolic process;8.3601675469523e-15!GO:0032553;ribonucleotide binding;1.22946510943473e-14!GO:0032555;purine ribonucleotide binding;1.22946510943473e-14!GO:0043285;biopolymer catabolic process;1.39436174286125e-14!GO:0017076;purine nucleotide binding;2.25800924400575e-14!GO:0042775;organelle ATP synthesis coupled electron transport;2.52763230043126e-14!GO:0042773;ATP synthesis coupled electron transport;2.52763230043126e-14!GO:0006457;protein folding;2.83510030397524e-14!GO:0016604;nuclear body;2.99718167327235e-14!GO:0006464;protein modification process;3.24320524259049e-14!GO:0008135;translation factor activity, nucleic acid binding;4.12676072837099e-14!GO:0030964;NADH dehydrogenase complex (quinone);4.62652231848358e-14!GO:0045271;respiratory chain complex I;4.62652231848358e-14!GO:0005747;mitochondrial respiratory chain complex I;4.62652231848358e-14!GO:0043228;non-membrane-bound organelle;6.01304436266201e-14!GO:0043232;intracellular non-membrane-bound organelle;6.01304436266201e-14!GO:0009057;macromolecule catabolic process;6.8372671363146e-14!GO:0005842;cytosolic large ribosomal subunit (sensu Eukaryota);1.22904273314764e-13!GO:0006120;mitochondrial electron transport, NADH to ubiquinone;1.59019981261888e-13!GO:0016651;oxidoreductase activity, acting on NADH or NADPH;3.8323138098201e-13!GO:0043687;post-translational protein modification;6.95410807803112e-13!GO:0005730;nucleolus;7.66122279339517e-13!GO:0016192;vesicle-mediated transport;1.14379833189625e-12!GO:0005761;mitochondrial ribosome;1.49406379101412e-12!GO:0000313;organellar ribosome;1.49406379101412e-12!GO:0012505;endomembrane system;3.8645014099997e-12!GO:0006913;nucleocytoplasmic transport;3.98563891008134e-12!GO:0006732;coenzyme metabolic process;4.10029279457995e-12!GO:0006413;translational initiation;4.33863519067149e-12!GO:0048770;pigment granule;4.93469031284942e-12!GO:0042470;melanosome;4.93469031284942e-12!GO:0006974;response to DNA damage stimulus;5.71788697656794e-12!GO:0051169;nuclear transport;7.41754365413104e-12!GO:0016607;nuclear speck;7.82596183472696e-12!GO:0042981;regulation of apoptosis;8.39040913910729e-12!GO:0003743;translation initiation factor activity;9.26208800278686e-12!GO:0005773;vacuole;9.56659948489731e-12!GO:0006325;establishment and/or maintenance of chromatin architecture;1.37578924603926e-11!GO:0000398;nuclear mRNA splicing, via spliceosome;1.37578924603926e-11!GO:0000375;RNA splicing, via transesterification reactions;1.37578924603926e-11!GO:0000377;RNA splicing, via transesterification reactions with bulged adenosine as nucleophile;1.37578924603926e-11!GO:0043067;regulation of programmed cell death;1.4364568670137e-11!GO:0005524;ATP binding;1.64781356934504e-11!GO:0032559;adenyl ribonucleotide binding;2.7516279979763e-11!GO:0006323;DNA packaging;5.05820319853117e-11!GO:0030554;adenyl nucleotide binding;6.09640368056045e-11!GO:0030163;protein catabolic process;6.67424417825782e-11!GO:0006446;regulation of translational initiation;8.14250158917743e-11!GO:0000323;lytic vacuole;8.3317439219193e-11!GO:0005764;lysosome;8.3317439219193e-11!GO:0005768;endosome;1.43394114024493e-10!GO:0046961;hydrogen ion transporting ATPase activity, rotational mechanism;1.65958306206724e-10!GO:0016787;hydrolase activity;2.03088193340463e-10!GO:0008639;small protein conjugating enzyme activity;2.12116242064828e-10!GO:0015078;hydrogen ion transmembrane transporter activity;3.47588297134004e-10!GO:0006793;phosphorus metabolic process;3.97537187443132e-10!GO:0006796;phosphate metabolic process;3.97537187443132e-10!GO:0005635;nuclear envelope;4.17561066277433e-10!GO:0009259;ribonucleotide metabolic process;4.65315659902236e-10!GO:0016887;ATPase activity;4.84290607420787e-10!GO:0051276;chromosome organization and biogenesis;4.8481475933222e-10!GO:0004842;ubiquitin-protein ligase activity;4.8481475933222e-10!GO:0009152;purine ribonucleotide biosynthetic process;5.06080957445453e-10!GO:0042623;ATPase activity, coupled;5.17729656219068e-10!GO:0046933;hydrogen ion transporting ATP synthase activity, rotational mechanism;5.35042290331776e-10!GO:0006164;purine nucleotide biosynthetic process;5.49655315726363e-10!GO:0043122;regulation of I-kappaB kinase/NF-kappaB cascade;6.10497734612129e-10!GO:0006163;purine nucleotide metabolic process;6.53271674054309e-10!GO:0003712;transcription cofactor activity;6.55758370916695e-10!GO:0009150;purine ribonucleotide metabolic process;6.7798255575563e-10!GO:0017038;protein import;9.82932227376645e-10!GO:0009260;ribonucleotide biosynthetic process;1.19793580820661e-09!GO:0019787;small conjugating protein ligase activity;1.44657336670139e-09!GO:0005794;Golgi apparatus;1.55399456586585e-09!GO:0051246;regulation of protein metabolic process;1.84939944031182e-09!GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB cascade;1.92907660636064e-09!GO:0015986;ATP synthesis coupled proton transport;2.29960650036063e-09!GO:0015985;energy coupled proton transport, down electrochemical gradient;2.29960650036063e-09!GO:0019829;cation-transporting ATPase activity;2.36000629376128e-09!GO:0051082;unfolded protein binding;2.4550769817277e-09!GO:0050794;regulation of cellular process;3.28696965426804e-09!GO:0006281;DNA repair;3.34656702518549e-09!GO:0051188;cofactor biosynthetic process;4.51432805199015e-09!GO:0048193;Golgi vesicle transport;4.74081580060433e-09!GO:0007249;I-kappaB kinase/NF-kappaB cascade;5.38313309364466e-09!GO:0016310;phosphorylation;6.52487943265285e-09!GO:0007049;cell cycle;8.03288269611343e-09!GO:0009055;electron carrier activity;9.67443821914779e-09!GO:0042254;ribosome biogenesis and assembly;1.12567222036107e-08!GO:0007243;protein kinase cascade;1.13803656595827e-08!GO:0016469;proton-transporting two-sector ATPase complex;1.16677680941135e-08!GO:0009142;nucleoside triphosphate biosynthetic process;1.39509279171504e-08!GO:0009201;ribonucleoside triphosphate biosynthetic process;1.39509279171504e-08!GO:0009206;purine ribonucleoside triphosphate biosynthetic process;1.40924096397667e-08!GO:0009145;purine nucleoside triphosphate biosynthetic process;1.40924096397667e-08!GO:0031965;nuclear membrane;1.47519577053894e-08!GO:0015077;monovalent inorganic cation transmembrane transporter activity;1.56328809408969e-08!GO:0006754;ATP biosynthetic process;1.73286171791599e-08!GO:0006753;nucleoside phosphate metabolic process;1.73286171791599e-08!GO:0044453;nuclear membrane part;1.81510645438949e-08!GO:0009060;aerobic respiration;1.84229301513117e-08!GO:0009056;catabolic process;2.28588056429894e-08!GO:0005783;endoplasmic reticulum;2.53358682532717e-08!GO:0008565;protein transporter activity;3.30201165536483e-08!GO:0007242;intracellular signaling cascade;3.77629192618277e-08!GO:0065002;intracellular protein transport across a membrane;4.24765130454579e-08!GO:0009199;ribonucleoside triphosphate metabolic process;4.56706751430639e-08!GO:0016879;ligase activity, forming carbon-nitrogen bonds;4.5798341175582e-08!GO:0005839;proteasome core complex (sensu Eukaryota);4.60458326835742e-08!GO:0009205;purine ribonucleoside triphosphate metabolic process;4.80229210933892e-08!GO:0009144;purine nucleoside triphosphate metabolic process;4.80229210933892e-08!GO:0050657;nucleic acid transport;4.83532336442069e-08!GO:0051236;establishment of RNA localization;4.83532336442069e-08!GO:0050658;RNA transport;4.83532336442069e-08!GO:0009141;nucleoside triphosphate metabolic process;5.78831373049696e-08!GO:0065004;protein-DNA complex assembly;6.02920572476654e-08!GO:0048523;negative regulation of cellular process;6.42638440436148e-08!GO:0005643;nuclear pore;6.79889040229276e-08!GO:0009108;coenzyme biosynthetic process;7.11136140990356e-08!GO:0006403;RNA localization;7.62616353758891e-08!GO:0016568;chromatin modification;8.82295538019355e-08!GO:0051726;regulation of cell cycle;9.1208971130421e-08!GO:0016591;DNA-directed RNA polymerase II, holoenzyme;1.04218707601263e-07!GO:0046034;ATP metabolic process;1.05786040151603e-07!GO:0008026;ATP-dependent helicase activity;1.08423696744673e-07!GO:0065009;regulation of a molecular function;1.16717959212219e-07!GO:0055086;nucleobase, nucleoside and nucleotide metabolic process;1.1921329044828e-07!GO:0000074;regulation of progression through cell cycle;1.21645154083545e-07!GO:0004386;helicase activity;1.29291576319332e-07!GO:0016881;acid-amino acid ligase activity;1.31306056646583e-07!GO:0045333;cellular respiration;1.71008723915576e-07!GO:0006333;chromatin assembly or disassembly;1.75249045528753e-07!GO:0005694;chromosome;1.93277405295086e-07!GO:0006417;regulation of translation;2.15547829418103e-07!GO:0009719;response to endogenous stimulus;2.2371095057512e-07!GO:0005770;late endosome;2.64930927437419e-07!GO:0004298;threonine endopeptidase activity;2.72417173581684e-07!GO:0006366;transcription from RNA polymerase II promoter;2.7897433601272e-07!GO:0030532;small nuclear ribonucleoprotein complex;3.6388334052058e-07!GO:0006399;tRNA metabolic process;4.1477217230449e-07!GO:0051170;nuclear import;4.69153719578208e-07!GO:0044432;endoplasmic reticulum part;4.75451879794201e-07!GO:0019222;regulation of metabolic process;5.22768510410347e-07!GO:0045786;negative regulation of progression through cell cycle;5.92515546646649e-07!GO:0043566;structure-specific DNA binding;6.71571318201657e-07!GO:0006606;protein import into nucleus;9.12153259450064e-07!GO:0045259;proton-transporting ATP synthase complex;9.98882749761915e-07!GO:0046930;pore complex;1.10716809057703e-06!GO:0003713;transcription coactivator activity;1.12525071409634e-06!GO:0043069;negative regulation of programmed cell death;1.20139555917434e-06!GO:0022402;cell cycle process;1.20139555917434e-06!GO:0051028;mRNA transport;1.31051975442039e-06!GO:0043066;negative regulation of apoptosis;1.48690324608705e-06!GO:0016072;rRNA metabolic process;1.68269917857067e-06!GO:0006752;group transfer coenzyme metabolic process;1.77794459613145e-06!GO:0048519;negative regulation of biological process;1.85055057796194e-06!GO:0003697;single-stranded DNA binding;1.99078488042094e-06!GO:0009117;nucleotide metabolic process;2.4199564594954e-06!GO:0006364;rRNA processing;2.6033245274211e-06!GO:0006099;tricarboxylic acid cycle;2.7216571852387e-06!GO:0046356;acetyl-CoA catabolic process;2.7216571852387e-06!GO:0009615;response to virus;3.02803955309076e-06!GO:0032446;protein modification by small protein conjugation;3.09391818490124e-06!GO:0006916;anti-apoptosis;3.28305704136034e-06!GO:0031324;negative regulation of cellular metabolic process;3.35044761093568e-06!GO:0016779;nucleotidyltransferase activity;3.76979719671172e-06!GO:0007005;mitochondrion organization and biogenesis;3.91697063372044e-06!GO:0044427;chromosomal part;3.95440469738644e-06!GO:0051187;cofactor catabolic process;4.22651816461328e-06!GO:0006084;acetyl-CoA metabolic process;4.53917243972181e-06!GO:0005774;vacuolar membrane;4.78098288854187e-06!GO:0016567;protein ubiquitination;4.78098288854187e-06!GO:0016740;transferase activity;4.90488643853682e-06!GO:0042175;nuclear envelope-endoplasmic reticulum network;5.0792388552163e-06!GO:0005789;endoplasmic reticulum membrane;5.26168216876662e-06!GO:0031326;regulation of cellular biosynthetic process;5.81378683306242e-06!GO:0050789;regulation of biological process;6.16882290719332e-06!GO:0043065;positive regulation of apoptosis;6.73221053434964e-06!GO:0044440;endosomal part;7.15580590101904e-06!GO:0010008;endosome membrane;7.15580590101904e-06!GO:0000785;chromatin;7.40488182547929e-06!GO:0000245;spliceosome assembly;7.57049133498694e-06!GO:0016564;transcription repressor activity;7.95789583941331e-06!GO:0007264;small GTPase mediated signal transduction;9.68768653050459e-06!GO:0005793;ER-Golgi intermediate compartment;1.00200062106284e-05!GO:0043068;positive regulation of programmed cell death;1.027685413063e-05!GO:0006461;protein complex assembly;1.10348737167623e-05!GO:0005525;GTP binding;1.10549971698143e-05!GO:0009967;positive regulation of signal transduction;1.16680004503609e-05!GO:0044437;vacuolar part;1.62030799949257e-05!GO:0031497;chromatin assembly;1.66976661845499e-05!GO:0042625;ATPase activity, coupled to transmembrane movement of ions;1.76678264134108e-05!GO:0000151;ubiquitin ligase complex;1.81392900452875e-05!GO:0031323;regulation of cellular metabolic process;2.03245733566535e-05!GO:0019899;enzyme binding;2.11991229430381e-05!GO:0009109;coenzyme catabolic process;2.17621429533439e-05!GO:0015931;nucleobase, nucleoside, nucleotide and nucleic acid transport;2.19918456991817e-05!GO:0006334;nucleosome assembly;2.24856714726553e-05!GO:0009889;regulation of biosynthetic process;2.37702428252427e-05!GO:0006888;ER to Golgi vesicle-mediated transport;2.43642291176681e-05!GO:0008654;phospholipid biosynthetic process;2.59198411246466e-05!GO:0031252;leading edge;2.63225843912119e-05!GO:0005762;mitochondrial large ribosomal subunit;2.79415155509486e-05!GO:0000315;organellar large ribosomal subunit;2.79415155509486e-05!GO:0008047;enzyme activator activity;2.93962434570942e-05!GO:0048475;coated membrane;3.20804953687722e-05!GO:0030117;membrane coat;3.20804953687722e-05!GO:0016772;transferase activity, transferring phosphorus-containing groups;3.22518804202194e-05!GO:0015405;P-P-bond-hydrolysis-driven transmembrane transporter activity;3.35053252069733e-05!GO:0015399;primary active transmembrane transporter activity;3.35053252069733e-05!GO:0022890;inorganic cation transmembrane transporter activity;3.70577922101973e-05!GO:0016876;ligase activity, forming aminoacyl-tRNA and related compounds;3.72440554456201e-05!GO:0004812;aminoacyl-tRNA ligase activity;3.72440554456201e-05!GO:0016875;ligase activity, forming carbon-oxygen bonds;3.72440554456201e-05!GO:0006917;induction of apoptosis;3.80854497052887e-05!GO:0030120;vesicle coat;3.80976997448064e-05!GO:0030662;coated vesicle membrane;3.80976997448064e-05!GO:0045934;negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;3.91565623240711e-05!GO:0050790;regulation of catalytic activity;4.08709113888128e-05!GO:0016563;transcription activator activity;4.11857080624009e-05!GO:0005765;lysosomal membrane;4.2163229534633e-05!GO:0016197;endosome transport;4.67743163089385e-05!GO:0003924;GTPase activity;4.82060393364617e-05!GO:0012502;induction of programmed cell death;5.53950918878872e-05!GO:0031202;RNA splicing factor activity, transesterification mechanism;5.63829911736665e-05!GO:0006818;hydrogen transport;6.09188649121455e-05!GO:0008632;apoptotic program;6.15160067802203e-05!GO:0043038;amino acid activation;6.42903548704166e-05!GO:0006418;tRNA aminoacylation for protein translation;6.42903548704166e-05!GO:0043039;tRNA aminoacylation;6.42903548704166e-05!GO:0006613;cotranslational protein targeting to membrane;6.6382763714818e-05!GO:0015992;proton transport;6.694873205691e-05!GO:0006091;generation of precursor metabolites and energy;7.24075854825328e-05!GO:0009892;negative regulation of metabolic process;9.46208946778719e-05!GO:0016481;negative regulation of transcription;0.000105184995196754!GO:0008234;cysteine-type peptidase activity;0.000116872685283028!GO:0031902;late endosome membrane;0.00012181423718726!GO:0006401;RNA catabolic process;0.000124160283859205!GO:0032561;guanyl ribonucleotide binding;0.000129279580437532!GO:0019001;guanyl nucleotide binding;0.000129279580437532!GO:0005885;Arp2/3 protein complex;0.000154996289238443!GO:0051168;nuclear export;0.000160129588611394!GO:0003724;RNA helicase activity;0.000168032735918617!GO:0051336;regulation of hydrolase activity;0.000207980289676882!GO:0009165;nucleotide biosynthetic process;0.00025672479629379!GO:0030695;GTPase regulator activity;0.000257894516064536!GO:0048522;positive regulation of cellular process;0.000269099128889411!GO:0006950;response to stress;0.000272897749526784!GO:0007034;vacuolar transport;0.000326815819238788!GO:0005753;mitochondrial proton-transporting ATP synthase complex;0.000341365820775304!GO:0010468;regulation of gene expression;0.000356130397396572!GO:0006612;protein targeting to membrane;0.000383507320537689!GO:0044262;cellular carbohydrate metabolic process;0.000459265476397208!GO:0003714;transcription corepressor activity;0.000468236606127916!GO:0005769;early endosome;0.000476638735837947!GO:0006402;mRNA catabolic process;0.000489069339640244!GO:0033178;proton-transporting two-sector ATPase complex, catalytic domain;0.000489069339640244!GO:0003729;mRNA binding;0.000517160230829143!GO:0043492;ATPase activity, coupled to movement of substances;0.000521419800125896!GO:0042626;ATPase activity, coupled to transmembrane movement of substances;0.000521419800125896!GO:0005852;eukaryotic translation initiation factor 3 complex;0.000531487145647868!GO:0030384;phosphoinositide metabolic process;0.000574561720371158!GO:0004674;protein serine/threonine kinase activity;0.000591047169771627!GO:0043681;protein import into mitochondrion;0.000647117730083275!GO:0045261;proton-transporting ATP synthase complex, catalytic core F(1);0.000651612091846039!GO:0016820;hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances;0.000689011544804922!GO:0007050;cell cycle arrest;0.000699167045797483!GO:0000314;organellar small ribosomal subunit;0.000732273077123092!GO:0005763;mitochondrial small ribosomal subunit;0.000732273077123092!GO:0005667;transcription factor complex;0.000732757319487849!GO:0005798;Golgi-associated vesicle;0.000732757319487849!GO:0051427;hormone receptor binding;0.000737601074553592!GO:0043021;ribonucleoprotein binding;0.000742994745230501!GO:0005096;GTPase activator activity;0.000776937108964641!GO:0046489;phosphoinositide biosynthetic process;0.000880323410646636!GO:0043623;cellular protein complex assembly;0.000887171756574141!GO:0006260;DNA replication;0.000960741825258724!GO:0005813;centrosome;0.000969139409322696!GO:0016679;oxidoreductase activity, acting on diphenols and related substances as donors;0.000985214414465901!GO:0016681;oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor;0.000985214414465901!GO:0008121;ubiquinol-cytochrome-c reductase activity;0.000985214414465901!GO:0006650;glycerophospholipid metabolic process;0.000991937360413681!GO:0065007;biological regulation;0.00106752680463595!GO:0046474;glycerophospholipid biosynthetic process;0.00115990373632731!GO:0001726;ruffle;0.00117655114844959!GO:0006350;transcription;0.00117655114844959!GO:0003690;double-stranded DNA binding;0.001251892160084!GO:0007265;Ras protein signal transduction;0.00127481625145442!GO:0008186;RNA-dependent ATPase activity;0.00131670222113011!GO:0035257;nuclear hormone receptor binding;0.00134819058754355!GO:0044431;Golgi apparatus part;0.00134819058754355!GO:0007041;lysosomal transport;0.00142886742986!GO:0016491;oxidoreductase activity;0.00145980897392086!GO:0003899;DNA-directed RNA polymerase activity;0.00147103879118854!GO:0000786;nucleosome;0.00164393288250507!GO:0016044;membrane organization and biogenesis;0.00164629949411983!GO:0048518;positive regulation of biological process;0.00170593721379191!GO:0006352;transcription initiation;0.00184367315107438!GO:0000278;mitotic cell cycle;0.00192700937342972!GO:0004197;cysteine-type endopeptidase activity;0.00195690639449412!GO:0006414;translational elongation;0.00202944847385847!GO:0045454;cell redox homeostasis;0.00205454701026092!GO:0031982;vesicle;0.00208119868666076!GO:0019843;rRNA binding;0.00208682140147447!GO:0045263;proton-transporting ATP synthase complex, coupling factor F(o);0.00216428137681279!GO:0033177;proton-transporting two-sector ATPase complex, proton-transporting domain;0.00216428137681279!GO:0043087;regulation of GTPase activity;0.00216569652191415!GO:0002474;antigen processing and presentation of peptide antigen via MHC class I;0.00238680843875963!GO:0005741;mitochondrial outer membrane;0.00250835731387889!GO:0015980;energy derivation by oxidation of organic compounds;0.00255752457365097!GO:0007040;lysosome organization and biogenesis;0.00265474944909575!GO:0005815;microtubule organizing center;0.00271371044371625!GO:0031072;heat shock protein binding;0.00276806631162873!GO:0016251;general RNA polymerase II transcription factor activity;0.00301389141150287!GO:0030530;heterogeneous nuclear ribonucleoprotein complex;0.00302017468669257!GO:0006626;protein targeting to mitochondrion;0.00311421541572562!GO:0000287;magnesium ion binding;0.00325669920829369!GO:0004004;ATP-dependent RNA helicase activity;0.00338233700246958!GO:0046467;membrane lipid biosynthetic process;0.00364979797939473!GO:0033116;ER-Golgi intermediate compartment membrane;0.00417404179518985!GO:0051325;interphase;0.00417446837101778!GO:0005838;proteasome regulatory particle (sensu Eukaryota);0.00417446837101778!GO:0009966;regulation of signal transduction;0.00423629426814317!GO:0006611;protein export from nucleus;0.00424811367817561!GO:0051540;metal cluster binding;0.00446573753512919!GO:0051536;iron-sulfur cluster binding;0.00446573753512919!GO:0046483;heterocycle metabolic process;0.00446573753512919!GO:0016676;oxidoreductase activity, acting on heme group of donors, oxygen as acceptor;0.00446573753512919!GO:0015002;heme-copper terminal oxidase activity;0.00446573753512919!GO:0016675;oxidoreductase activity, acting on heme group of donors;0.00446573753512919!GO:0004129;cytochrome-c oxidase activity;0.00446573753512919!GO:0051329;interphase of mitotic cell cycle;0.00452807194887026!GO:0051252;regulation of RNA metabolic process;0.00470576891853675!GO:0033033;negative regulation of myeloid cell apoptosis;0.0047600583600396!GO:0001803;regulation of type III hypersensitivity;0.0047600583600396!GO:0032733;positive regulation of interleukin-10 production;0.0047600583600396!GO:0033025;regulation of mast cell apoptosis;0.0047600583600396!GO:0001805;positive regulation of type III hypersensitivity;0.0047600583600396!GO:0033023;mast cell homeostasis;0.0047600583600396!GO:0002431;Fc receptor mediated stimulatory signaling pathway;0.0047600583600396!GO:0033032;regulation of myeloid cell apoptosis;0.0047600583600396!GO:0001802;type III hypersensitivity;0.0047600583600396!GO:0033028;myeloid cell apoptosis;0.0047600583600396!GO:0042590;antigen processing and presentation of exogenous peptide antigen via MHC class I;0.0047600583600396!GO:0033026;negative regulation of mast cell apoptosis;0.0047600583600396!GO:0033024;mast cell apoptosis;0.0047600583600396!GO:0004437;inositol or phosphatidylinositol phosphatase activity;0.004767070696424!GO:0051539;4 iron, 4 sulfur cluster binding;0.00478843490398278!GO:0008033;tRNA processing;0.00499910861782522!GO:0009607;response to biotic stimulus;0.0051780591350219!GO:0005083;small GTPase regulator activity;0.00521890901270373!GO:0006357;regulation of transcription from RNA polymerase II promoter;0.00532502863763218!GO:0016853;isomerase activity;0.00532980430845269!GO:0016363;nuclear matrix;0.00533808056747943!GO:0043281;regulation of caspase activity;0.00538400601111516!GO:0007006;mitochondrial membrane organization and biogenesis;0.00560452174083395!GO:0032940;secretion by cell;0.00581023290544681!GO:0019219;regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.0059255909604274!GO:0007033;vacuole organization and biogenesis;0.00594278494989051!GO:0051090;regulation of transcription factor activity;0.00597798001553565!GO:0006891;intra-Golgi vesicle-mediated transport;0.00598135895045962!GO:0031410;cytoplasmic vesicle;0.00642651637747958!GO:0006919;caspase activation;0.00654435868067035!GO:0043488;regulation of mRNA stability;0.00656747342935701!GO:0043487;regulation of RNA stability;0.00656747342935701!GO:0051789;response to protein stimulus;0.00657788696448535!GO:0006986;response to unfolded protein;0.00657788696448535!GO:0005684;U2-dependent spliceosome;0.00661141769376438!GO:0031988;membrane-bound vesicle;0.00752601265900329!GO:0006383;transcription from RNA polymerase III promoter;0.00761808309030419!GO:0031968;organelle outer membrane;0.007759622928896!GO:0006914;autophagy;0.00793177384222556!GO:0006261;DNA-dependent DNA replication;0.00794553674521886!GO:0030693;caspase activity;0.00803096143546651!GO:0019318;hexose metabolic process;0.00804764925948904!GO:0019867;outer membrane;0.0081619620029785!GO:0030176;integral to endoplasmic reticulum membrane;0.00868161585351723!GO:0016272;prefoldin complex;0.00885231522768707!GO:0005996;monosaccharide metabolic process;0.00903560823267804!GO:0006643;membrane lipid metabolic process;0.00903560823267804!GO:0060090;molecular adaptor activity;0.00928101014482866!GO:0000118;histone deacetylase complex;0.00956112820834927!GO:0003746;translation elongation factor activity;0.00960700363415671!GO:0046822;regulation of nucleocytoplasmic transport;0.00963424145426938!GO:0032318;regulation of Ras GTPase activity;0.00988858187302989!GO:0008624;induction of apoptosis by extracellular signals;0.0100036507870094!GO:0008333;endosome to lysosome transport;0.0100404648661165!GO:0016281;eukaryotic translation initiation factor 4F complex;0.0105846735449718!GO:0005637;nuclear inner membrane;0.0106671529374745!GO:0000139;Golgi membrane;0.0107055677720553!GO:0046519;sphingoid metabolic process;0.0107566237750992!GO:0005669;transcription factor TFIID complex;0.0110032701568381!GO:0048487;beta-tubulin binding;0.0110528087195701!GO:0016765;transferase activity, transferring alkyl or aryl (other than methyl) groups;0.0110528087195701!GO:0051920;peroxiredoxin activity;0.0113959389455388!GO:0031625;ubiquitin protein ligase binding;0.0114975327324942!GO:0016584;nucleosome positioning;0.011509399633997!GO:0043280;positive regulation of caspase activity;0.011509399633997!GO:0004518;nuclease activity;0.0115142526887798!GO:0045792;negative regulation of cell size;0.0116395997535891!GO:0002757;immune response-activating signal transduction;0.0116442521497318!GO:0004428;inositol or phosphatidylinositol kinase activity;0.0118574614818836!GO:0001816;cytokine production;0.0118574614818836!GO:0006302;double-strand break repair;0.0120060466559744!GO:0006506;GPI anchor biosynthetic process;0.0124248965746808!GO:0003725;double-stranded RNA binding;0.0125209754971001!GO:0016859;cis-trans isomerase activity;0.0128193862095607!GO:0048500;signal recognition particle;0.0128193862095607!GO:0046966;thyroid hormone receptor binding;0.0128535452291379!GO:0006310;DNA recombination;0.0130222740458699!GO:0030308;negative regulation of cell growth;0.013090274981987!GO:0045892;negative regulation of transcription, DNA-dependent;0.0130965391021836!GO:0030041;actin filament polymerization;0.0132062957381929!GO:0051087;chaperone binding;0.0132523833252315!GO:0045926;negative regulation of growth;0.0133073949091324!GO:0006672;ceramide metabolic process;0.0133912819215088!GO:0003755;peptidyl-prolyl cis-trans isomerase activity;0.0133912819215088!GO:0042802;identical protein binding;0.0134958500480505!GO:0030027;lamellipodium;0.0136044115330819!GO:0004527;exonuclease activity;0.0138203768595599!GO:0016023;cytoplasmic membrane-bound vesicle;0.0138973647750212!GO:0030867;rough endoplasmic reticulum membrane;0.0138973647750212!GO:0030258;lipid modification;0.0139422545406933!GO:0043022;ribosome binding;0.0140146412419164!GO:0006213;pyrimidine nucleoside metabolic process;0.0147372735288318!GO:0032981;mitochondrial respiratory chain complex I assembly;0.0148936148033858!GO:0010257;NADH dehydrogenase complex assembly;0.0148936148033858!GO:0033108;mitochondrial respiratory chain complex assembly;0.0148936148033858!GO:0005048;signal sequence binding;0.0149985694967392!GO:0008656;caspase activator activity;0.0155706126926398!GO:0032763;regulation of mast cell cytokine production;0.0156524966193964!GO:0032762;mast cell cytokine production;0.0156524966193964!GO:0006614;SRP-dependent cotranslational protein targeting to membrane;0.0157080661733331!GO:0045047;protein targeting to ER;0.0157080661733331!GO:0018193;peptidyl-amino acid modification;0.0160872018497559!GO:0030663;COPI coated vesicle membrane;0.016365953007762!GO:0030126;COPI vesicle coat;0.016365953007762!GO:0006595;polyamine metabolic process;0.0163741946250896!GO:0048468;cell development;0.0166870360587484!GO:0008180;signalosome;0.0166870360587484!GO:0008270;zinc ion binding;0.0168321445359137!GO:0008312;7S RNA binding;0.0171534134538073!GO:0008637;apoptotic mitochondrial changes;0.0183180365983665!GO:0030137;COPI-coated vesicle;0.0184644921152598!GO:0006505;GPI anchor metabolic process;0.0186573376932102!GO:0004722;protein serine/threonine phosphatase activity;0.018794681705063!GO:0006497;protein amino acid lipidation;0.0189218369997586!GO:0003711;transcription elongation regulator activity;0.0190148790675026!GO:0005869;dynactin complex;0.0191477585388459!GO:0002764;immune response-regulating signal transduction;0.0195122214888027!GO:0045947;negative regulation of translational initiation;0.0198233416275407!GO:0030658;transport vesicle membrane;0.0199165994964746!GO:0046914;transition metal ion binding;0.0199165994964746!GO:0004218;cathepsin S activity;0.0199165994964746!GO:0030518;steroid hormone receptor signaling pathway;0.0199165994964746!GO:0006607;NLS-bearing substrate import into nucleus;0.0199165994964746!GO:0006839;mitochondrial transport;0.0202180546679715!GO:0006367;transcription initiation from RNA polymerase II promoter;0.021076590678914!GO:0030118;clathrin coat;0.0211074735752485!GO:0009893;positive regulation of metabolic process;0.0215187149026514!GO:0050811;GABA receptor binding;0.0216323069553616!GO:0006405;RNA export from nucleus;0.0219034374745949!GO:0004185;serine carboxypeptidase activity;0.0219163003669013!GO:0009116;nucleoside metabolic process;0.0225147569171478!GO:0006458;'de novo' protein folding;0.0225716495460965!GO:0051084;'de novo' posttranslational protein folding;0.0225716495460965!GO:0005057;receptor signaling protein activity;0.0227070042900371!GO:0006013;mannose metabolic process;0.0229331141309679!GO:0006118;electron transport;0.0230847847947905!GO:0019864;IgG binding;0.0238692486716688!GO:0000209;protein polyubiquitination;0.0242852721068992!GO:0005786;signal recognition particle, endoplasmic reticulum targeting;0.0243789868423291!GO:0051098;regulation of binding;0.0249673916740274!GO:0002504;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;0.0257617691557941!GO:0006376;mRNA splice site selection;0.0258408857503197!GO:0000389;nuclear mRNA 3'-splice site recognition;0.0258408857503197!GO:0043433;negative regulation of transcription factor activity;0.0259397339285202!GO:0016788;hydrolase activity, acting on ester bonds;0.0259439178702677!GO:0006644;phospholipid metabolic process;0.0261866208741885!GO:0006007;glucose catabolic process;0.0263395518389646!GO:0032774;RNA biosynthetic process;0.0263395518389646!GO:0003988;acetyl-CoA C-acyltransferase activity;0.0263543273069124!GO:0000082;G1/S transition of mitotic cell cycle;0.0263909493719243!GO:0008287;protein serine/threonine phosphatase complex;0.0266341385766979!GO:0005975;carbohydrate metabolic process;0.0266771520751213!GO:0006740;NADPH regeneration;0.0266771520751213!GO:0006098;pentose-phosphate shunt;0.0266771520751213!GO:0030145;manganese ion binding;0.0266771520751213!GO:0015923;mannosidase activity;0.0267261429050506!GO:0051235;maintenance of localization;0.0267694577894088!GO:0006778;porphyrin metabolic process;0.0269679265094237!GO:0033013;tetrapyrrole metabolic process;0.0269679265094237!GO:0046983;protein dimerization activity;0.0269679265094237!GO:0045449;regulation of transcription;0.027002988442881!GO:0006509;membrane protein ectodomain proteolysis;0.0273824994945283!GO:0033619;membrane protein proteolysis;0.0273824994945283!GO:0043300;regulation of leukocyte degranulation;0.0285949841592372!GO:0006351;transcription, DNA-dependent;0.0289136704121922!GO:0048002;antigen processing and presentation of peptide antigen;0.0289136704121922!GO:0045045;secretory pathway;0.0291384694350922!GO:0022403;cell cycle phase;0.029496257243936!GO:0030833;regulation of actin filament polymerization;0.0295888938354044!GO:0000184;mRNA catabolic process, nonsense-mediated decay;0.0305751379971969!GO:0008168;methyltransferase activity;0.0307960890641917!GO:0009112;nucleobase metabolic process;0.0308435196245326!GO:0000305;response to oxygen radical;0.0309103959101377!GO:0000049;tRNA binding;0.0310669662453562!GO:0000119;mediator complex;0.0311560338833838!GO:0006897;endocytosis;0.0314093750968391!GO:0010324;membrane invagination;0.0314093750968391!GO:0005832;chaperonin-containing T-complex;0.0314563514606166!GO:0009119;ribonucleoside metabolic process;0.0317664125744849!GO:0030036;actin cytoskeleton organization and biogenesis;0.0320093209898004!GO:0000303;response to superoxide;0.0320594378089054!GO:0004177;aminopeptidase activity;0.0320631889737088!GO:0048471;perinuclear region of cytoplasm;0.0322615646168495!GO:0002429;immune response-activating cell surface receptor signaling pathway;0.0324066314427577!GO:0032640;tumor necrosis factor production;0.0325245701812362!GO:0008139;nuclear localization sequence binding;0.032541559880918!GO:0006733;oxidoreduction coenzyme metabolic process;0.0329217678539553!GO:0002822;regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains.;0.0329217678539553!GO:0002819;regulation of adaptive immune response;0.0329217678539553!GO:0015036;disulfide oxidoreductase activity;0.0336230704609751!GO:0051223;regulation of protein transport;0.0338401305356863!GO:0007021;tubulin folding;0.0341902351676172!GO:0008538;proteasome activator activity;0.0344740882036383!GO:0016741;transferase activity, transferring one-carbon groups;0.0348736132108736!GO:0007007;inner mitochondrial membrane organization and biogenesis;0.0354013451822528!GO:0043621;protein self-association;0.0355102340181929!GO:0009127;purine nucleoside monophosphate biosynthetic process;0.0356389049333799!GO:0009167;purine ribonucleoside monophosphate metabolic process;0.0356389049333799!GO:0009126;purine nucleoside monophosphate metabolic process;0.0356389049333799!GO:0009168;purine ribonucleoside monophosphate biosynthetic process;0.0356389049333799!GO:0006289;nucleotide-excision repair;0.0358655022585871!GO:0006368;RNA elongation from RNA polymerase II promoter;0.0363233739129377!GO:0031901;early endosome membrane;0.0367159386649441!GO:0045935;positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.0367387569195194!GO:0030660;Golgi-associated vesicle membrane;0.0373831135637801!GO:0017091;AU-rich element binding;0.0375742848052206!GO:0050779;RNA destabilization;0.0375742848052206!GO:0000289;poly(A) tail shortening;0.0375742848052206!GO:0032760;positive regulation of tumor necrosis factor production;0.0376394629784503!GO:0004532;exoribonuclease activity;0.0376394629784503!GO:0016896;exoribonuclease activity, producing 5'-phosphomonoesters;0.0376394629784503!GO:0042771;DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis;0.0377852027773406!GO:0008320;protein transmembrane transporter activity;0.0378190739398542!GO:0006767;water-soluble vitamin metabolic process;0.0378190739398542!GO:0022415;viral reproductive process;0.0378190739398542!GO:0033367;protein localization in mast cell secretory granule;0.0378190739398542!GO:0033365;protein localization in organelle;0.0378190739398542!GO:0033371;T cell secretory granule organization and biogenesis;0.0378190739398542!GO:0033373;maintenance of protease localization in mast cell secretory granule;0.0378190739398542!GO:0033375;protease localization in T cell secretory granule;0.0378190739398542!GO:0042629;mast cell granule;0.0378190739398542!GO:0033377;maintenance of protein localization in T cell secretory granule;0.0378190739398542!GO:0033364;mast cell secretory granule organization and biogenesis;0.0378190739398542!GO:0033380;granzyme B localization in T cell secretory granule;0.0378190739398542!GO:0033379;maintenance of protease localization in T cell secretory granule;0.0378190739398542!GO:0033370;maintenance of protein localization in mast cell secretory granule;0.0378190739398542!GO:0033368;protease localization in mast cell secretory granule;0.0378190739398542!GO:0033366;protein localization in secretory granule;0.0378190739398542!GO:0033382;maintenance of granzyme B localization in T cell secretory granule;0.0378190739398542!GO:0033374;protein localization in T cell secretory granule;0.0378190739398542!GO:0015631;tubulin binding;0.0398153446377908!GO:0000178;exosome (RNase complex);0.0399252721444411!GO:0005070;SH3/SH2 adaptor activity;0.0403091973760082!GO:0030330;DNA damage response, signal transduction by p53 class mediator;0.0406253079261888!GO:0016791;phosphoric monoester hydrolase activity;0.0410400614997372!GO:0005062;hematopoietin/interferon-class (D200-domain) cytokine receptor signal transducer activity;0.0413087746463769!GO:0051101;regulation of DNA binding;0.0414294748171104!GO:0016505;apoptotic protease activator activity;0.041434971252159!GO:0045185;maintenance of protein localization;0.0425697993891288!GO:0005099;Ras GTPase activator activity;0.0429108639649637!GO:0042168;heme metabolic process;0.0432171381911045!GO:0031647;regulation of protein stability;0.0435301029044202!GO:0042158;lipoprotein biosynthetic process;0.0436630971399266!GO:0045309;protein phosphorylated amino acid binding;0.0442723690897079!GO:0030503;regulation of cell redox homeostasis;0.0446352639966605!GO:0016605;PML body;0.0448763952192317!GO:0019883;antigen processing and presentation of endogenous antigen;0.0450339977122299!GO:0016773;phosphotransferase activity, alcohol group as acceptor;0.0450480689539486!GO:0016301;kinase activity;0.0450480689539486!GO:0016408;C-acyltransferase activity;0.0452348276920735!GO:0016311;dephosphorylation;0.0452348276920735!GO:0008286;insulin receptor signaling pathway;0.0457220129399687!GO:0000288;mRNA catabolic process, deadenylation-dependent decay;0.0466440495557629!GO:0004576;oligosaccharyl transferase activity;0.047123738509583!GO:0030132;clathrin coat of coated pit;0.0477584103178989!GO:0005665;DNA-directed RNA polymerase II, core complex;0.0484189802314301!GO:0043284;biopolymer biosynthetic process;0.0484189802314301!GO:0016780;phosphotransferase activity, for other substituted phosphate groups;0.0488956516096578!GO:0006516;glycoprotein catabolic process;0.0489186222016064!GO:0051059;NF-kappaB binding;0.0490249241478864!GO:0030218;erythrocyte differentiation;0.0492778589182843!GO:0002467;germinal center formation;0.0496157852740047!GO:0035258;steroid hormone receptor binding;0.0498740134321582 | |||
|sample_id=11790 | |sample_id=11790 | ||
|sample_note= | |sample_note= |
Revision as of 17:22, 25 June 2012
Name: | CD14-CD16+ Monocytes, donor1 |
---|---|
Species: | Human (Homo sapiens) |
Library ID: | {{{library_id}}} |
Sample type: | {{{sample_category}}} |
Genomic View: | UCSC |
CAGEd-oPOSSUM: | link |
Additional information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sample information
RNA information
|
Download raw sequence, BAM & CTSS | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Relative expression to median (log10)
Transcription factors with enriched expression in this sampleRanked list of transcription factor promoter expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed.
Co-expression clusters with enriched expression in this sampleRanked list of co-expression cluster expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed. <br>Analyst:NA <br><br>link to dataset.<br>data
Repeat families with enriched expression in this sample<b>Summary:</b>Ranked list of repeat family expression in this sample relative tothe median expression in the FANTOM5 collection is shown. Value is log10transformed.<br><b>Analyst:</b>NA<br><br>link to dataset.<br>data
no result for this sample
TFBS(DNA)motifs over-represented in proximal region of promoters active in this sample
JASPAR motifs<b>Summary:</b>Association of JASPAR motif to the promoter expression in thissample. Pearson's correlation between the number of TFBSs estimated byusing the position-weight matrix for each promoter and its expression isexpressed as Z-score by taking the ones based on random position-weightmatrix, and the tail probability of the normal distribution correspondingto the Z-score is taken as the resulting P-value. Lower P-value indicatesmore (non-random) association of the motif to promoter expression<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs13229
FANTOM5 phase1 novel unique motifs<b>Summary:</b>Association of the 169 novel and unique motifs discovered in FANTOM5 phase1 in this sample. Among the de-novo motifs discovered by DMF, HOMER,ChIPMunk, and ScanAll, only novel motifs are selected after comparison with known motif sets, and their clustering based on MACRO-APE resulted in169 novel and unique motifs. Their association to the promoter expression is evaluated in the same way to the JASPAR motif above<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs13229
Novel motif | Logo | P-value |
---|---|---|
1 | 1 | 0.144 |
10 | 10 | 0.0335 |
100 | 100 | 0.913 |
101 | 101 | 0.41 |
102 | 102 | 0.568 |
103 | 103 | 0.41 |
104 | 104 | 0.564 |
105 | 105 | 0.0813 |
106 | 106 | 0.0117 |
107 | 107 | 0.911 |
108 | 108 | 0.73 |
109 | 109 | 0.028 |
11 | 11 | 0.235 |
110 | 110 | 0.194 |
111 | 111 | 0.0861 |
112 | 112 | 0.287 |
113 | 113 | 0.432 |
114 | 114 | 0.0178 |
115 | 115 | 0.368 |
116 | 116 | 0.764 |
117 | 117 | 0.0172 |
118 | 118 | 0.0997 |
119 | 119 | 0.246 |
12 | 12 | 0.186 |
120 | 120 | 0.6 |
121 | 121 | 0.749 |
122 | 122 | 0.682 |
123 | 123 | 0.00165 |
124 | 124 | 0.261 |
125 | 125 | 0.253 |
126 | 126 | 0.173 |
127 | 127 | 0.509 |
128 | 128 | 0.0997 |
129 | 129 | 0.874 |
13 | 13 | 0.0715 |
130 | 130 | 0.308 |
131 | 131 | 0.622 |
132 | 132 | 0.036 |
133 | 133 | 0.15 |
134 | 134 | 0.663 |
135 | 135 | 0.315 |
136 | 136 | 0.657 |
137 | 137 | 8.08814e-5 |
138 | 138 | 0.341 |
139 | 139 | 0.00878 |
14 | 14 | 0.397 |
140 | 140 | 0.247 |
141 | 141 | 0.805 |
142 | 142 | 0.972 |
143 | 143 | 0.0544 |
144 | 144 | 0.938 |
145 | 145 | 0.443 |
146 | 146 | 0.985 |
147 | 147 | 0.475 |
148 | 148 | 0.0339 |
149 | 149 | 0.615 |
15 | 15 | 0.128 |
150 | 150 | 0.589 |
151 | 151 | 0.222 |
152 | 152 | 0.205 |
153 | 153 | 0.647 |
154 | 154 | 0.975 |
155 | 155 | 0.102 |
156 | 156 | 0.943 |
157 | 157 | 0.732 |
158 | 158 | 0.105 |
159 | 159 | 0.158 |
16 | 16 | 0.596 |
160 | 160 | 0.713 |
161 | 161 | 0.505 |
162 | 162 | 0.353 |
163 | 163 | 0.258 |
164 | 164 | 0.191 |
165 | 165 | 0.106 |
166 | 166 | 0.275 |
167 | 167 | 0.128 |
168 | 168 | 0.533 |
169 | 169 | 0.015 |
17 | 17 | 0.325 |
18 | 18 | 0.228 |
19 | 19 | 0.365 |
2 | 2 | 0.93 |
20 | 20 | 0.343 |
21 | 21 | 0.491 |
22 | 22 | 0.209 |
23 | 23 | 0.316 |
24 | 24 | 0.265 |
25 | 25 | 0.146 |
26 | 26 | 0.0405 |
27 | 27 | 0.671 |
28 | 28 | 0.501 |
29 | 29 | 0.111 |
3 | 3 | 0.0954 |
30 | 30 | 0.335 |
31 | 31 | 0.639 |
32 | 32 | 0.703 |
33 | 33 | 0.192 |
34 | 34 | 0.526 |
35 | 35 | 0.21 |
36 | 36 | 0.0378 |
37 | 37 | 0.0528 |
38 | 38 | 0.501 |
39 | 39 | 0.867 |
4 | 4 | 0.898 |
40 | 40 | 0.0917 |
41 | 41 | 0.0416 |
42 | 42 | 0.259 |
43 | 43 | 0.0743 |
44 | 44 | 0.879 |
45 | 45 | 0.898 |
46 | 46 | 0.18 |
47 | 47 | 0.471 |
48 | 48 | 0.484 |
49 | 49 | 0.0874 |
5 | 5 | 0.0785 |
50 | 50 | 0.968 |
51 | 51 | 0.396 |
52 | 52 | 0.381 |
53 | 53 | 0.252 |
54 | 54 | 0.411 |
55 | 55 | 0.396 |
56 | 56 | 0.832 |
57 | 57 | 0.978 |
58 | 58 | 0.0416 |
59 | 59 | 0.157 |
6 | 6 | 0.812 |
60 | 60 | 0.0487 |
61 | 61 | 0.165 |
62 | 62 | 0.0212 |
63 | 63 | 0.542 |
64 | 64 | 0.436 |
65 | 65 | 0.349 |
66 | 66 | 0.39 |
67 | 67 | 0.493 |
68 | 68 | 0.524 |
69 | 69 | 0.688 |
7 | 7 | 0.157 |
70 | 70 | 0.0374 |
71 | 71 | 0.0398 |
72 | 72 | 0.314 |
73 | 73 | 0.114 |
74 | 74 | 0.411 |
75 | 75 | 0.0296 |
76 | 76 | 0.203 |
77 | 77 | 0.636 |
78 | 78 | 0.249 |
79 | 79 | 0.753 |
8 | 8 | 0.508 |
80 | 80 | 0.255 |
81 | 81 | 0.235 |
82 | 82 | 0.181 |
83 | 83 | 0.675 |
84 | 84 | 0.55 |
85 | 85 | 0.0679 |
86 | 86 | 0.0827 |
87 | 87 | 0.233 |
88 | 88 | 0.617 |
89 | 89 | 0.888 |
9 | 9 | 0.316 |
90 | 90 | 0.0995 |
91 | 91 | 0.463 |
92 | 92 | 0.569 |
93 | 93 | 0.394 |
94 | 94 | 0.0464 |
95 | 95 | 0.00829 |
96 | 96 | 0.3 |
97 | 97 | 0.955 |
98 | 98 | 0.0976 |
99 | 99 | 0.0816 |
de novo motifs identified by HOMER in promoters active in this sample<b>Summary:</b>The result of HOMER in this sample is shown.<br><b>Analyst:</b>NA <br>
library id: CNhs13229
FANTOM5 (FF) ontology
Direct parent terms
is_a relathionship
EFO:0002091 biological replicate
FF:0000002 in vivo cell sample
FF:0000210 human sample
FF:0011100 human CD14-CD16-positive Monocytes sample
Ancestor terms (non development)<b>Summary:</b>Connected ontology terms with is_a, part_of or located_in relationship <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source data<br>data
CL: Cell type
0000000 (cell), 0000000 (cell)
0000003 (native cell)
0000723 (somatic stem cell)
0000048 (multi fate stem cell)
0000988 (hematopoietic cell)
0000839 (myeloid lineage restricted progenitor cell)
0000548 (animal cell)
0002194 (monopoietic cell)
0000034 (stem cell)
0002032 (hematopoietic oligopotent progenitor cell)
0000763 (myeloid cell)
0002320 (connective tissue cell)
0002371 (somatic cell)
0000766 (myeloid leukocyte)
0000219 (motile cell)
0000134 (mesenchymal cell)
0000738 (leukocyte)
0002087 (nongranular leukocyte)
0000255 (eukaryotic cell)
0002031 (hematopoietic lineage restricted progenitor cell)
0000576 (monocyte)
0000037 (hematopoietic stem cell)
0000860 (classical monocyte)
0000875 (non-classical monocyte)
0002393 (intermediate monocyte)
0000566 (angioblastic mesenchymal cell)
0002397 (CD14-positive, CD16-positive monocyte)
0000049 (common myeloid progenitor)
0000557 (granulocyte monocyte progenitor cell)
0000837 (hematopoietic multipotent progenitor cell)
0002396 (CD14-low, CD16-positive monocyte)
0002057 (CD14-positive, CD16-negative classical monocyte)
0002009 (macrophage dendritic cell progenitor)
0000040 (monoblast)
0000559 (promonocyte)
UBERON: Anatomy
0000468 (multi-cellular organism)
0000922 (embryo)
0002371 (bone marrow)
0001474 (bone element)
0002384 (connective tissue)
0000926 (mesoderm)
0000479 (tissue)
0000062 (organ)
0004765 (skeletal element)
0004120 (mesoderm-derived structure)
0000061 (anatomical structure)
0000465 (material anatomical entity)
0000480 (anatomical group)
0000923 (germ layer)
0002050 (embryonic structure)
0005423 (developing anatomical structure)
0000467 (anatomical system)
0001062 (anatomical entity)
0005291 (embryonic tissue)
0006598 (presumptive structure)
0002532 (epiblast (generic))
0002204 (musculoskeletal system)
0001434 (skeletal system)
0002390 (hematopoietic system)
0002193 (hemolymphoid system)
0002405 (immune system)
0003081 (lateral plate mesoderm)
0006603 (presumptive mesoderm)
0003061 (blood island)
FF: FANTOM5
NA
Ancestor terms (development)<b>Summary:</b>Connected ontology terms with develops_from, derives_from or preceded_by relationship <br><b>Analyst:</b> Hideya Kawaji <br><br>link to source data<br>data
NA